seed
Stage
About
Path Therapeutics is a biotech company developing novel neurometabolic drug discovery platforms to identify new therapeutic targets for epilepsy and other brain disorders, focusing initially on pediatric epilepsies like Dravet Syndrome.
Explore Path Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.